Aprezo 30mg (Apremilast 30mg.)

What is Aprezo 30mg (Apremilast 30mg.)?

Aprezo 30mg (Apremilast 30mg.) is a prescription oral medication used to manage moderate to severe plaque psoriasis in adults. It belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors, which help reduce inflammation linked to psoriatic symptoms. This treatment is typically prescribed when patients cannot tolerate or do not respond to traditional therapies such as phototherapy or systemic agents like methotrexate.

Key features

• Active Ingredient — Apremilast 30mg per tablet, a targeted PDE4 inhibitor.
• Indication — Treats moderate to severe plaque psoriasis in eligible adults.
• Dosing — Taken orally twice daily, with gradual titration to minimize side effects.
• Non-biologic — Offers an alternative to injectable biologics with oral administration.
• Prescription Required — Not available over-the-counter; must be authorized by a licensed physician.
• Manufactured To Standards — Produced under strict quality controls for pharmaceutical consistency.
• Storage — Store at room temperature, away from moisture and light.

Who is Aprezo 30mg (Apremilast 30mg.) for?

This medication is intended for adults with active plaque psoriasis who have failed or cannot use conventional systemic treatments. It may benefit those seeking an oral, non-immunosuppressive option without injections. Patients with a history of depression or severe kidney impairment should consult their doctor before use.

How does Aprezo 30mg (Apremilast 30mg.) compare?

Compared to biologic therapies, Aprezo 30mg offers oral convenience without refrigeration or injection requirements. It acts more selectively than broad immunosuppressants like methotrexate, potentially reducing long-term risks. However, it may take several weeks to show visible skin improvement and is not suitable for all patients, particularly those with certain mental health conditions.